cryptocurrency is a- Top Related searches

Yushi Technology: There is no factual basis for the company to be included in the "entity list". At present, the production and operation are normal. Yushi Technology issued a statement today: On December 10, 2024 (Beijing time), the Bureau of Industry and Security of the US Department of Commerce issued relevant announcements to include companies such as Yushi Technology in the entity list. There is no factual basis for this decision, and the company has never received any investigation and evidence collection work from any official US agency. We call on the US government to re-examine. Yushi Technology is an independent private enterprise. As a global provider of AloT products, solutions and full-stack capabilities, Yushi Technology has always adhered to the internationally accepted business ethics and compliance management concept since its establishment 13 years ago, abided by the duties of commercial companies and strictly abided by the laws and regulations of the countries where it operates. At present, the company's production and operation are normal, and this incident has no significant adverse impact on the company's operation. We have the ability to ensure continuous and stable product supply and high-quality technical support for global customers.Spot gold just broke through the $2,690.00/oz mark, and the latest price was $2,689.72/oz, down 0.15% in the day.Vietnam Customs: In November, the coffee export was 63,019 tons; Rubber exports are 230,574 tons.

Academician Qiao Jie, Executive Vice President of Peking University, and his party visited Sunflower Pharmaceutical Group. On December 9th, Academician Qiao Jie, Executive Vice President of Peking University, and his party visited the headquarters of Sunflower Pharmaceutical Group for investigation and exchange. At the symposium, Tan Lei, general manager of the strategic management department of Sunflower Pharmaceutical Group, gave a detailed report on the promotion plan of the project "Peking University Medical-Sunflower Pharmaceutical Group Joint Laboratory of Bacterial Enzyme and Innovative Drugs". Sunflower Pharmaceutical Group will join hands with Peking University Medical Center, and the teams of the two sides will cooperate in depth to jointly develop new drugs based on the active substances of traditional Chinese medicine and the discovered important disease targets, promote the transformation of scientific research achievements, deepen the advantageous fields of biotechnology, and help improve the scientific research and innovation ability and technology development level. During the talks, the two sides also conducted in-depth exchanges and discussions on a number of contents.Private placement: Positive factors in the stock market are accumulating. Recently, A-shares have fluctuated, and the latest strategies of many first-line private placements for investment at the end of the year and the beginning of the year have been released one after another. A number of private placements are optimistic about the market at the end of the year. Kou Zhiwei, a partner of chongyang investment, said that the "strengthening unconventional countercyclical adjustment" proposed by the policy at the end of the year inspired market confidence. At present, compared with the end of September, the market has a large increase, and the market has fully expected and priced the policy overweight. The further rise of the short-term market may need the support of strong economic recovery data. Judging from the recent overall investment trends of private placement, the reporter found that maintaining medium and high positions and maintaining high flexibility of portfolios have become the strategic focus of current private placement institutions. (CSI)Sony Group's share price hit a record high in intraday trading, and Sony Group's share price broke through the high of 3,390 yen set in 2000, reaching a record high.

India's NIFTY metal index rose by 1.25%.Academician Qiao Jie, Executive Vice President of Peking University, and his party visited Sunflower Pharmaceutical Group. On December 9th, Academician Qiao Jie, Executive Vice President of Peking University, and his party visited the headquarters of Sunflower Pharmaceutical Group for investigation and exchange. At the symposium, Tan Lei, general manager of the strategic management department of Sunflower Pharmaceutical Group, gave a detailed report on the promotion plan of the project "Peking University Medical-Sunflower Pharmaceutical Group Joint Laboratory of Bacterial Enzyme and Innovative Drugs". Sunflower Pharmaceutical Group will join hands with Peking University Medical Center, and the teams of the two sides will cooperate in depth to jointly develop new drugs based on the active substances of traditional Chinese medicine and the discovered important disease targets, promote the transformation of scientific research achievements, deepen the advantageous fields of biotechnology, and help improve the scientific research and innovation ability and technology development level. During the talks, the two sides also conducted in-depth exchanges and discussions on a number of contents.The "moderately loose" monetary policy boosted the confidence of all parties. A50ETF Huabao (159596) attracted 17.02 million yuan of gold yesterday. On December 11, the Shanghai Composite Index fluctuated within a narrow range in the morning, and A50ETF Huabao (159596) fell slightly by 0.18% with a turnover of 84.21 million yuan. In terms of constituent stocks, the top ten awkward stocks are mixed. On the upside, Midea Group led the gains, followed by Zijin Mining and Changjiang Power. On the downside, Hengrui Pharma led the decline. In terms of capital flow, A50ETF Huabao (159596) received a net inflow of 17.02 million yuan yesterday. China Post Securities said that the the Political Bureau of the Communist Party of China (CPC) Central Committee meeting continued to actively set the tone, and the policy turned loose, and expanding domestic demand in all directions became the current policy direction. This meeting made it clear that "strengthening unconventional countercyclical adjustment" and the fiscal policy adjustment was "more active", which basically met market expectations; The monetary policy is set to be "moderately loose", and the tone is adjusted again after 14 years. Next year, it is expected to be wide in currency and credit.